regulatory

Market Access

Streamlining JCA response with GenAI

The Joint Clinical Assessment (JCA) framework took effect on 12th January 2025, and its impact is top of mind among pharma innovators today.

News

RFK Jr unorthodox vaccine views on show in interview

Robert F Kennedy Jr's controversial views on vaccines were on display this week during an interview that touched on delays to a COVID-19 shot review.

News

FDA plans to phase out animal testing for antibodies

The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods.

News

Surgeon with surgical gloves on holding a brain scan

Lilly to appeal after CHMP rejects Alzheimer's drug Kisunla

The CHMP has advised against EU approval of Eli Lilly's Alzheimer's drug Kisunla, potentially handing an advantage to Eisai/Biogen's rival drug.

News

HHS plans 10,000 more job cuts, taking target to 20,000

HHS Secretary Kennedy has said he intends to save $1.8bn per year, thanks to another wave of job cuts affecting the FDA, CDC, NIH, and CMS.

News

Jean-François Toussaint, Sanofi's global head of vaccines R&D

FDA fast-tracks Sanofi's experimental chlamydia vaccine

Sanofi is preparing to start human testing of its chlamydia vaccine, now fast-tracked by the FDA, that it hopes will be the first to reach the market.

Streamlining JCA response with GenAI

RFK Jr unorthodox vaccine views on show in interview

FDA plans to phase out animal testing for antibodies

Lilly to appeal after CHMP rejects Alzheimer's drug Kisunla

HHS plans 10,000 more job cuts, taking target to 20,000

FDA fast-tracks Sanofi's experimental chlamydia vaccine

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

regulatory

Editor's Picks